Cannabidiol (CBD)

The relationship between cannabis and anxiety is an interesting one. Large concentrations of tetrahydrocannabinol (THC) is often tied to bouts of paranoia and anxiety, however it is well-documented that cannabidiol (CBD) found in cannabis can counteract this effect. With that said, a group of Brazilian researchers published an article in the 2011 Journal of Psychopharmacology that further investigates the relationship between cannabidiol (CBD) and Social Anxiety Disorder (SAD). Their results suggest that CBD could offer a way …

For years now Δ9-tetrahydrocannabinol (THC) has been the most popular and widely researched cannabinoid in cannabis science. However, nowadays it seems like cannabidiol (CBD) has stolen the spotlight given its ability to provide therapeutic relief to children suffering from various epileptic disorders, while lacking the psychotropic effects (i.e. high) of THC. It’s even gotten to the point that state legislature are passing laws “CBD-only” medical marijuana legislation. Given all of this, it is easy to see how CBD and THC can be viewed …

There is a great deal of evidence suggesting that cannabis is beneficial for the prevention and treatment of neurodegenerative diseases. It shows particular promise in the case of Alzheimer’s disease, and Clint Werner covers the topic in detail in his book Marijuana Gateway to Health. With that said, a group of Australian researchers, led by Dr. Tim Karl, published a study in this month’s edition of Psychopharmacology that offers further insight. It suggests …

COLUMBIA, SC — In what is the result of an increased interest in cannabidiol (CBD), a limited medical marijuana initiative was passed Thursday by a South Carolina House Committee. Proposed by Representative Jenny Horne (R-Summerville), “Julian’s Act” would allow the use of CBD-rich cannabis extracts in the case of severe epilepsy. It is named in honor of a 3-year-old epilepsy patient from South Carolina, whose family is moving to Colorado so that they can treat his symptoms with CBD-rich cannabis …

For years the faulty argument has been made that cannabis causes and/or increases the likelihood of schizophrenia. Of course, much of this position has already been debunked in one way or another. A study published in 2004 determined that cannabis can help counter psychosis; another study published last year found that cannabidiol (CBD) can help improve cognitive function in schizophrenic individuals. Accordingly, a number …

It is no secret that alcohol consumption can negatively affect one’s liver. This is because it can cause an excess of fats and lipids and additional oxidative stress (i.e. damage caused by free radicals). With that said, a recent study published in Free Radical Biology and Medicine offers an interesting preventive measure. Funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institutes of Health (NIH), it suggests that cannabidiol (CBD) could help protect the liver from alcohol-induced damage. Researchers …

As we know, cannabis extracts have been reported to treat a number of ailments. There have been a number of anecdotal success stories, leading to an increased interest in cannabis concentrates (RSO, BHO, Solventless Wax, etc.) as a viable treatment option. Following suit, a recent study adds a …

Glioma is the term used to describe a tumor that originated on the brain or spine. Each year, 10,000 Americans are diagnosed with malignant glioma. Of those, about half will die within a year of diagnosis. Only 25 percent are still alive after two years. Researchers Investigated Glioma & Its Reaction To Cannabinoids Most often occurring in the brain, malignant gliomas are rarely curable despite years of research on the subject. Traditional therapies like radiotherapy and chemotherapy have had limited success, and glioma’s ability to spread to normal tissue makes surgery difficult. “Each year, 10,000 Americans are diagnosed with malignant …

It is no secret that tetrahydrocannabinol (THC) received the most attention in the past as far as cannabinoids are concerned. Growers in search of strains with the strongest high used selective breeding techniques to build their plants’ THC levels over time. Interest In Cannabidiol (CBD) Research Is Rising “CBD has grabbed the attention of breeders across America.” As a result, cannabis testing labs across the US began reporting THC results above 25%, but at a price. Many of these strains were, and still are, incredibly low in …

First Clinical Trial For Cannabis-Based Cancer Therapy GW Pharmaceuticals, based in the UK, announced Monday that they have commenced phase 1b/2a clinical trials to study the potential benefits of Sativex in the treatment of Recurrent Glioblastoma Multiforme (GBM) – an aggressive form of brain cancer that accounts for 50% of new US brain cancer diagnoses. “GW Pharmaceuticals becomes the first entity to conduct clinical research on cannabis-based cancer treatment with humans.” For those unfamiliar with it, Sativex is an sublingual spray that was scientifically formulated to contain a 1:1 ratio between tetrahydrocannabinol (THC) …